{"entity":{"id":"ospedali-galliera","kind":"institution","name":"E.O. Ospedali Galliera","aka":["Galliera Hospital","Ospedale Galliera Genova"],"tldr":"Genoa hospital whose medical oncology division, under Andrea DeCensi, ran TAM-01, the trial that showed low-dose tamoxifen prevents breast cancer recurrence after non-invasive disease.","summary":"The Ospedali Galliera is a public hospital in the centre of Genoa. Its Division of Medical Oncology, led by Andrea DeCensi, has specialised in breast cancer prevention and low-dose drug strategies, coordinating TAM-01, the Italian randomised trial reported in the Journal of Clinical Oncology in 2019 in which tamoxifen at 5 mg a day reduced recurrence and new breast cancers after ductal carcinoma in situ and other non-invasive lesions.","asOf":"2026-09-18","links":[{"label":"Ospedali Galliera","url":"https://www.galliera.it"}],"tags":[],"related":[],"cancers":["breast-hr-positive"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["andrea-decensi"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Genoa","country":"IT","lat":44.399,"lng":8.947,"institutionType":"hospital","website":"https://www.galliera.it","programs":["Breast cancer prevention","Low-dose tamoxifen trials"]},"route":"/institutions/ospedali-galliera/","neighbours":{"cancer":[{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"}],"person":[{"id":"andrea-decensi","kind":"person","name":"Andrea DeCensi","route":"/people/andrea-decensi/"}]}}